JAMA - Journal of the American Medical Association




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight InfantsThe ETTNO Randomized Clinical Trial

Axel R. Franz, MD; Corinna Engel, PhD; Dirk Bassler, MD; et al.

doi : 10.1001/jama.2020.10690

JAMA. 2020;324(6):560-570. 

This randomized clinical trial assesses the effect of liberal vs restrictive red blood cell transfusion thresholds (based on postnatal age and current health state) on death or disability at 24 months of age among extremely low-birth-weight infants.

Buy The Package and View The Article Online


Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in ChildrenThe BLINK Randomized Clinical Trial

Jeffrey J. Walline, OD, PhD; Maria K. Walker, OD, PhD; Donald O. Mutti, OD, PhD; et al.

doi : 10.1001/jama.2020.10834

JAMA. 2020;324(6):571-580. 

This randomized trial compares the effects of higher add power (+2.50 D) vs lower add power (+1.50 D) soft multifocal contact lenses vs single-vision contact lenses on myopia progression at 3 years in children aged 7 to 11 years with myopia.

Buy The Package and View The Article Online


Association of Nonoperative Management Using Antibiotic Therapy vs Laparoscopic Appendectomy With Treatment Success and Disability Days in Children With Uncomplicated Appendicitis

Peter C. Minneci, MD, MHSc; Erinn M. Hade, PhD; Amy E. Lawrence, MD; et al.

doi : 10.1001/jama.2020.10888

JAMA. 2020;324(6):581-593. 

This nonrandomized controlled trial allowed children with appendicitis and their families to choose antibiotic therapy vs laparoscopic appendectomy as initial management, and compares 1-year disability days and treatment success—no need for later surgery—between the groups.

Buy The Package and View The Article Online


COVID-19 Cases and Deaths in Federal and State Prisons

Brendan Saloner, PhD; Kalind Parish, MA; Julie A. Ward, MN, RN; et al.

doi : 10.1001/jama.2020.12528

JAMA. 2020;324(6):602-603. 

This study describes coronavirus disease 2019 (COVID-19) case rates and deaths among federal and state prisoners and compares them with corresponding rates for the US population.

Buy The Package and View The Article Online


Persistent Symptoms in Patients After Acute COVID-19

Angelo Carf?, MD; Roberto Bernabei, MD; Francesco Landi, MD, PhD; et al.

doi : 10.1001/jama.2020.12603

JAMA. 2020;324(6):603-605.

This case series describes COVID-19 symptoms persisting a mean of 60 days after onset among Italian patients previously discharged from COVID-19 hospitalization.

Buy The Package and View The Article Online


Trends in Daily Use of Biotin Supplements Among US Adults, 1999-2016

Danni Li, PhD; Mary R. Rooney, PhD, MPH; Lynn A. Burmeister, MD; et al.

doi : 10.1001/jama.2020.8144

JAMA. 2020;324(6):605-607.

This pharmacoepidemiology study uses NHANES data to characterize the prevalence and trends in use of high-dosage biotin supplementation among US adults between 1999 and 2016.

Buy The Package and View The Article Online


The Work of Philanthropy in Responding to COVID-19 and Addressing InequalityA New Foundation

Darren Walker, JD

doi : 10.1001/jama.2020.12904

JAMA. 2020;324(6):541-542.

In this Viewpoint the president of the Ford Foundation calls on philanthropic and other wealthy organizations to make creative and generous grants to less well-endowed counterpart institutions and communities to redress the racial and socioeconomic disparities exposed by the COVID-19 pandemic and continued killings of Black Americans.

Buy The Package and View The Article Online


Pooling Data From Individual Clinical Trials in the COVID-19 Era

Eva Petkova, PhD; Elliott M. Antman, MD; Andrea B. Troxel, ScD

doi : 10.1001/jama.2020.13042

JAMA. 2020;324(6):543-545.

This Viewpoint proposes principles and processes to allow pooling of individual patient data from clinical trials given decelerating participant recruitment at sites where the COVID-19 surge has been controlled and new cases are diminishing.

Buy The Package and View The Article Online


The Advisory Committee on Immunization Practices and Its Role in the Pandemic Vaccine Response

Grace M. Lee, MD, MPH; Beth P. Bell, MD, MPH; José R. Romero, MD

doi : 10.1001/jama.2020.13167

JAMA. 2020;324(6):546-547. 

This Viewpoint discusses the role of the Advisory Committee on Immunization Practices, a federal advisory committee that makes vaccine-related recommendations to the CDC and DHHS, in guiding the development and deployment of COVID-19 vaccines.

Buy The Package and View The Article Online


COVID-19 Response in LebanonCurrent Experience and Challenges in a Low-Resource Setting

Petra Khoury, PharmD; Eid Azar, MD; Eveline Hitti, MD, MBA

doi : 10.1001/jama.2020.12695

JAMA. 2020;324(6):548-549.

This Viewpoint describes the unique challenges faced by Lebanon, a small densely populated country with a fragmented health care system, in its response to the emerging COVID-19 pandemic, and it summarizes organizational, testing, and communications policies the nation has implemented that might be useful to other resource-limited countries and settings.

Buy The Package and View The Article Online


Prevention of Unintentional Medication Overdose Among ChildrenTime for the Promise of the Poison Prevention Packaging Act to Come to Fruition

Daniel S. Budnitz, MD, MPH; Maribeth C. Lovegrove, MPH; Robert J. Geller, MD

doi : 10.1001/jama.2020.2152

JAMA. 2020;324(6):550-551. 

This Viewpoint discusses the success of US legislation to help prevent medication overdoses in children and suggests strategies to continue to reduce these overdoses, including changes to child-resistant packaging.

Buy The Package and View The Article Online


Clinical, Legal, and Ethical Aspects of Artificial Intelligence–Assisted Conversational Agents in Health Care

John D. McGreevey III, MD; C. William Hanson III, MD; Ross Koppel, PhD

doi : 10.1001/jama.2020.2724

JAMA. 2020;324(6):552-553.

This Viewpoint discusses evidence supporting use of conversational agents in health care—artificial intelligence (AI) programs that interpret users’ questions or concerns and respond with answers—and proposes 12 domains (eg, safety, transparency, security) that clinicians and health care organizations should evaluate before using them for patient care.

Buy The Package and View The Article Online


The Convergence of Neurology and PsychiatryThe Importance of Cross-Disciplinary Education

Matcheri S. Keshavan, MD; Bruce H. Price, MD; Joseph B. Martin, MD, PhD

doi : 10.1001/jama.2020.0062

JAMA. 2020;324(6):554-555.

This Viewpoint reviews the historical convergence and then divergence of psychiatry and neurology as clinical disciplines and calls for a transformation of graduate and postgraduate education to integrate the two and span intersections of the humanities, philosophy, and science.

Buy The Package and View The Article Online


Good for Us All

Rachel B. Issaka, MD, MAS

doi : 10.1001/jama.2020.12630

JAMA. 2020;324(6):556-557. 

In this narrative medicine essay, a gastroenterologist recalls a microagression from a patient during fellowship training and realizes the fault lay with the medicine profession and calls for antiracist training as one measure in dismantling race-based health disparities.

Buy The Package and View The Article Online


Reducing the Progression of Myopia

Neil M. Bressler, MD

doi : 10.1001/jama.2020.10953

JAMA. 2020;324(6):558-559.

Buy The Package and View The Article Online


Lipids and Lipoproteins in 2020

Brian A. Ference, MD, MPhil, MSc; John J. P. Kastelein, MD, PhD; Alberico L. Catapano, PhD

doi : 10.1001/jama.2020.5685

JAMA. 2020;324(6):595-596. 

This JAMA Insights Clinical Update reviews the central role of apolipoprotein B100 molecule (apoB)–containing lipoproteins in the development of atherosclerotic cardiovascular disease (ASCVD), with implications for patient risk assessment and choice of lipid-lowering therapy.

Buy The Package and View The Article Online


Management of Acute Pulmonary Embolism

Jonathan D. Paul, MD; Adam S. Cifu, MD

doi : 10.1001/jama.2020.3905

JAMA. 2020;324(6):597-598.

This JAMA Clinical Guidelines Synopsis summarizes the European Society of Cardiology’s 2019 guidelines for diagnosis and management of acute pulmonary embolism.

Buy The Package and View The Article Online


Abdominal Pain and an Appendiceal Mass

Roxanne L. Massoumi, MD; Jonathan C. King, MD

doi : 10.1001/jama.2020.4707

JAMA. 2020;324(6):599-600. 

A 68-year-old woman with history of uterine carcinoma (unknown histology) treated 30 years prior had 2 months of generalized abdominal pain and distention but no fever, nausea, vomiting, diarrhea, constipation, blood in the stool, or weight loss. CBC and serum chemistries were unremarkable; CT and MRI showed pelvic ascites and an enhancing lesion at the base of the cecum; CEA level was 18 ng/mL (normal <5 ng/mL). What is the diagnosis and what would you do next?

Buy The Package and View The Article Online


Success of Antibiotic Therapy vs Laparoscopic Appendectomy for Uncomplicated Appendicitis in ChildrenA Matter of Perspective

Edward H. Livingston, MD

doi : 10.1001/jama.2020.13381

JAMA. 2020;324(6):594. 

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?